Showing results (791-800 of 851) with videos related to

Sort By:
Pageof 86
Nature|August 24, 2018
Allergic inflammatory memory in human respiratory epithelial progenitor cellsJose Ordovas-Montanes, Daniel F Dwyer, Sarah K Nyquist, et al.
Pharmaceuticals (Basel, Switzerland)|June 26, 2026
Unilateral Adrenalectomy, and the Stable Pentadecapeptide BPC 157 as Therapy in Rats-A Cytoprotection ApproachIvan Maria Smoday, Vlasta Vukovic, Katarina Oroz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2021
Phase 1 Trial of ALRN-6924, a Dual Inhibitor of MDMX and MDM2, in Patients with Solid Tumors and Lymphomas Bearing Wild-type TP53Mansoor N Saleh, Manish R Patel, Todd M Bauer, et al.
Pharmaceuticals (Basel, Switzerland)|May 27, 2023
Stable Gastric Pentadecapeptide BPC 157 May Recover Brain-Gut Axis and Gut-Brain Axis FunctionPredrag Sikiric, Slaven Gojkovic, Ivan Krezic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2013
A multicenter phase II study of ganetespib monotherapy in patients with genotypically defined advanced non-small cell lung cancerMark A Socinski, Jonathan Goldman, Iman El-Hariry, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|November 16, 2024
Cyclosporin A toxicity on endothelial cells differentiated from induced pluripotent stem cells: Assembling an adverse outcome pathwayZahra Mazidi, Matthias Wieser, Nicoleta Spinu, et al.
Pharmaceuticals (Basel, Switzerland)|July 29, 2023
Antiarrhythmic Sotalol, Occlusion/Occlusion-like Syndrome in Rats, and Stable Gastric Pentadecapeptide BPC 157 TherapyIvica Premuzic Mestrovic, Ivan Maria Smoday, Luka Kalogjera, et al.
Pharmaceuticals (Basel, Switzerland)|November 25, 2023
Stable Gastric Pentadecapeptide BPC 157 Therapy: Effect on Reperfusion Following Maintained Intra-Abdominal Hypertension (Grade III and IV) in RatsMarijan Tepes, Ivan Krezic, Hrvoje Vranes, et al.
European Journal of Heart Failure|July 15, 2025
Cardio-microcurrent device treatment for heart failure with reduced ejection fraction: Results from the C-MIC II open-label randomized controlled trialJesus E Rame, Jan D Schmitto, Dragana N Kosevic, et al.
Pageof 86